Blog

Updates on the Bard PowerPort Lawsuit

The Bard PowerPort is an implanted port catheter designed to facilitate the intravenous delivery of fluids or medications. However, inherent design and manufacturing flaws have led to serious injuries such…
Filed Under: Industry Advice

Updates on the Dacthal (DCPA) Lawsuit

The Dacthal lawsuit continues to progress as plaintiffs allege that exposure to Dacthal, a widely used herbicide, has led to severe health complications including cancer, respiratory issues, and thyroid disorders.…
Filed Under: Industry Advice

Updates on the Semaglutide Lawsuit

This blog provides an update on the ongoing semaglutide lawsuit, outlining recent legal actions, key medical findings, and other important things to know. What are semaglutides? Semaglutide is a glucagon-like…
Filed Under: Industry Advice

Updates on the Depo-Provera Lawsuit

Depo-Provera, widely used as a female contraceptive injection for over three decades, has now been linked to a significantly increased risk of developing meningiomas, a type of brain tumor, according…
Filed Under: Industry Advice

Updates on the Paraquat Lawsuit

The paraquat lawsuit continues to evolve, with new cases and legal decisions impacting those affected by the commercial-strength herbicide. This blog provides a detailed overview and the latest updates on…
Filed Under: Industry Advice

Updates on the PFAS Contamination Lawsuit

Per- and polyfluoroalkyl substances, commonly known as PFAS, are a group of human-made chemicals that have been used in a multitude of industries for their grease and water-resistant properties. The…
Filed Under: Industry Advice

Updates on NEC Baby Formula Lawsuit

Across the United States, Necrotizing Enterocolitis (NEC) formula lawsuits are being pursued by families of premature infants who were diagnosed with NEC after being fed Similac or Enfamil baby formula.…
Filed Under: Industry Advice